Skip to content

Clinical trials

Hypercholesterolemia trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Country / region: Finland Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20053
20061
20071
20082
20112
20124
20132
20141
20151
20161
20181
20201
20213
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Active, not recruiting3
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen5
Sanofi5
Kowa Research Europe3
Merck Sharp & Dohme LLC2
Raisio Group2
AstraZeneca1
Coxa, Hospital for Joint Replacement1
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1
Marjukka Kolehmainen1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia27
Dyslipidemias7
Hyperlipidemias4
Atherosclerosis3
Obesity2
Anhedonia1
Cardiovascular Diseases1
Diabetes Mellitus, Type 21
Glucose Metabolism Disorders1
Hyperglycemia1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.